Page 2 - Nasdaq Rprx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq rprx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Rprx Today - Breaking & Trending Today

Aigen Investment Management LP Sells 14,105 Shares of Royalty Pharma plc (NASDAQ:RPRX)

Aigen Investment Management LP lessened its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 44.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,943 shares of the biopharmaceutical company’s stock after selling 14,105 shares during the […] ....

United States , Roryb Riggs , Vanguard Group Inc , Royalty Pharma Company Profile , Jpmorgan Chase Co , Blackrock Inc , Geode Capital Management , Morgan Stanley , Goldman Sachs Group , Avara Management Ltd , Securities Exchange Commission , Aigen Investment Management , Royalty Pharma , Free Report , Investment Management , Street Corp , Capital Management , Director Rory , Exchange Commission , Royalty Pharma Daily , Nasdaq Rprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Homestead Advisers Corp Increases Holdings in Royalty Pharma plc (NASDAQ:RPRX)

Homestead Advisers Corp grew its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,343,040 shares of the biopharmaceutical company’s stock after purchasing an additional 21,000 shares during the period. Homestead […] ....

United States , Roryb Riggs , Carson Advisory Inc , Morgan Stanley , Avara Management Ltd , Securities Exchange Commission , Exchange Commission , Homestead Advisers Corp , Eversource Wealth Advisors , Royalty Pharma , Free Report , Advisers Corp , Financial Advisors , Source Wealth Advisors , Director Rory , Get Free Report , Royalty Pharma Daily , Nasdaq Rprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

S&CO Inc. Acquires 29,390 Shares of Royalty Pharma plc (NASDAQ:RPRX)

S&CO Inc. boosted its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 13.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 253,610 shares of the biopharmaceutical company’s stock after buying an additional 29,390 shares during the period. […] ....

United States , Roryb Riggs , S Co Inc , Vanguard Group Inc , Morgan Stanley , Securities Exchange Commission , Avara Management Ltd , Exchange Commission , Blackrock Inc , Co Inc , Jpmorgan Chase Co , Geode Capital Management , Royalty Pharma , Free Report , Street Corp , Capital Management , Director Rory , Get Free Report , Visit Holdingschannel , Royalty Pharma Daily , Nasdaq Rprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Royalty Pharma (NASDAQ:RPRX) Trading 7.7% Higher

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report)’s stock price shot up 7.7% on Tuesday . The stock traded as high as $29.98 and last traded at $29.85. 3,518,855 shares were traded during trading, an increase of 58% from the average session volume of 2,230,688 shares. The stock had previously closed at $27.71. Analyst Ratings […] ....

United States , Roryb Riggs , Healthcare Of Ontario Pension Plan Trust Fund , Financial Services Group Inc , Securities Exchange Commission , Advisor Group Holdings Inc , Royalty Pharma Company Profile , Avara Management Ltd , Us Bancorp , Envestnet Asset Management Inc , Morgan Stanley , Royalty Pharma , Get Free Report , Director Rory , Exchange Commission , Asset Management , Group Holdings , Services Group , Ontario Pension Plan Trust Fund , Royalty Pharma Daily , Nasdaq Rprx ,

Royalty Pharma plc (NASDAQ:RPRX) Announces Quarterly Dividend of $0.21

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) announced a quarterly dividend on Monday, January 22nd, Wall Street Journal reports. Shareholders of record on Friday, February 16th will be paid a dividend of 0.21 per share by the biopharmaceutical company on Friday, March 15th. This represents a $0.84 dividend on an annualized basis and a […] ....

United States , Roryb Riggs , American Century Companies Inc , Mercer Global Advisors Inc , Envestnet Asset Management Inc , Sei Investments Co , Royalty Pharma Company Profile , Morgan Stanley , Royalty Pharma , Get Free Report , Wall Street Journal , Director Rory , Century Companies , Global Advisors , Envestnet Asset Management , Asset Management , Royalty Pharma Daily , Nasdaq Rprx ,